Advertisement

Pharmacy World and Science

, Volume 19, Issue 6, pp 279–282 | Cite as

Drug use and cognitive function in residents of homes for the elderly.

  • J.G.E. Janzing
  • M.A. van't Hof
  • F.G. Zitman
Article
  • 40 Downloads

Abstract

In order to investigate the relationship between cognitive function and daily used drugs in the elderly we performed an observational, cross–sectional study in 5 homes for the elderly in the region of Nijmegen, the Netherlands. Participants were 497 residents of these homes. For all these subjects the daily used drugs, classified according to the Anatomical Therapeutic Classification system, were registered and global cognitive function was measured as the total score on the Mini Mental State Examination. Adjusting for age and education, there was a small but significant and positive correlation between the use of metoprolol and the total MMSE score. The use of CNS drugs was not related to the total MMSE score. All eleven most frequently used drugs together explained 2.9% of the variance in the MMSE scores. These results indicate that there is a negligible association between daily drug use and cognitive function in these subjects.

Drugs Drug therapy Cognitive function Dementia Elderly subjects Homes for the elderly 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Potamianos G, Kellett JM. Anti-cholinergic drugs and memory: the effects of benzhexol on memory in a group of geriatric patients. Br J Psychiatry 1982;140:470–2.Google Scholar
  2. 2.
    Moskowitz H, Burns MM. Cognitive performance in geriatric subjects after acute treatment with antidepressants. Neuropsychobiology 1986;15:38–43 (suppl).Google Scholar
  3. 3.
    Satzger W, Engel RR, Ferguson E, Kapfhammer H, Eich FX, Hippius H. Effects of single doses of aldipem, lorazepam and placebo on memory and attention in healthy young and elderly volunteers. Pharmacopsychiatry 1990;23:114–9 (suppl).Google Scholar
  4. 4.
    Greenblatt DJ, Harmatz JS, Shapiro L, Engelhardt N, Gouthro TA, Shader RI. Sensitivity to triazolam in the elderly. N Engl J Med 1991;324:1691–8.Google Scholar
  5. 5.
    Tune L, Carr S, Hoag E, Cooper T. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry 1992;149:1393–4.Google Scholar
  6. 6.
    Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 1987;107:169–73.Google Scholar
  7. 7.
    Anonymous. Guidelines for ATC classification. Oslo: WHO Collaborating Center for drug statistics methodology. Uppsala: Nordic Counsel on medicines, 1990.Google Scholar
  8. 8.
    Folstein MF, Folstein SE, McHugh PR. Mini Mental State, a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98.Google Scholar
  9. 9.
    Cockrell JR, Folstein MF. Mini Mental State Examination (MMSE). Psychopharm Bull 1988;24(4):689–92.Google Scholar
  10. 10.
    Steele C, Lucas MJ, Tune L. Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type. J Clin psychiatry 1986;47:310–2.Google Scholar
  11. 11.
    van Riezen H, Segal M. Comparative evaluation of rating scales for clinical psychopharmacology. Amsterdam: Elsevier, 1988:369.Google Scholar
  12. 12.
    O'Connor DW, Pollitt PA, Treasure FP, Brook CPB, Reiss BB. The influence of education, social class and sex on Mini Mental State Scores. Psychol Med 1989;19:771–6.Google Scholar
  13. 13.
    Magaziner J, Bassett SS, Hebel JR. Predicting performance on the Mini Mental State Examination. Use of Age-and education-specific equations. J Am Geriatr Soc 1987;35:996–1000.Google Scholar
  14. 14.
    Anonymous. SPSS-X Data Analysis System, Release 4.0. Chicago: SPSS inc., 1990.Google Scholar
  15. 15.
    Van Loveren-Huyben CMS, Van der Bom JA. Het verzorgingshuis: een toenemende bron van zorg. Tijdschr Gerontol Geriatr 1983;14:199–206.Google Scholar
  16. 16.
    Mann AH, Graham N, Ashby D. Psychiatric illness in residential homes for the elderly: a survey in one London borough. Age Ageing 1984;13:257–65.Google Scholar
  17. 17.
    Clarke MG, Williams AJ, Jones PA. A psychogeriatric survey of old people's homes. BMJ 1981;283:1307–10.Google Scholar
  18. 18.
    Strikwerda P, Bootsma-de Langen AM, Derghuis F, Meyboomde Jong B. Farmacotherapie in een verzorgingshuis; gunstige invloed van feed-back door de apotheker op het voorschrijfgedrag van de huisarts. Ned Tijdschr Geneeskd 1994;138:1770–4.Google Scholar
  19. 19.
    Lishman WA. Senile dementias, presenile dementias and pseudodementias. In: Lishman WA. Organic Psychiatry, the psychological consequences of cerebral disorder. 2nd ed. Oxford: Blackwell Scientific Publications, 1987:370–427.Google Scholar
  20. 20.
    Gurland BJ, Teresi J, McFate Smith W, Black D, Hughes G, Edlavitch S. Effects of treatment for isolated systolic hypertension on cognitive status and depression in the elderly. J Am Geriatr Soc 1988;36:1015–22.Google Scholar
  21. 21.
    Farmer ME, White LR, Abbott RD, Kittner SJ, Kaplan E, Wolz MM et al. Blood pressure and cognitive performance. Am J Epidemiol 1987;126:1103–14.Google Scholar
  22. 22.
    Bailey RB, Jones SR. Chronic salicylate intoxication. A common cause of morbidity in the elderly. J Am Geriatr Soc 1989;37:556–61.Google Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • J.G.E. Janzing
    • 1
  • M.A. van't Hof
    • 1
  • F.G. Zitman
    • 1
  1. 1.Department of PsychiatryUniversity Hospital NijmegenNijmegenthe Netherlands

Personalised recommendations